These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis. Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366 [TBL] [Abstract][Full Text] [Related]
23. [Neuroleptic malignant syndrome. Case reports]. Berardi D; Troia M; Veronesi L; Ferrari G Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943 [TBL] [Abstract][Full Text] [Related]
24. Ocular complications related to phenothiazines. Siddall JR Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740 [No Abstract] [Full Text] [Related]
25. [The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments]. Lambert PA Encephale; 1971; 60(4):335-49. PubMed ID: 5004893 [No Abstract] [Full Text] [Related]
26. [Neuroleptic malignant syndrome. Reappraisal apropos of 2 cases]. Bourgeois M; Tignol J; Villeger M; Henry P; Daubech JF; Laforge E; Durand J Ann Med Psychol (Paris); 1981 May; 139(5):547-56. PubMed ID: 6118087 [No Abstract] [Full Text] [Related]
27. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal]. Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H Encephale; 1995; 21(3):209-15. PubMed ID: 7649071 [TBL] [Abstract][Full Text] [Related]
28. [Adverse effects of phenothiazines]. Roos BE Nord Psykiatr Tidsskr; 1968; 22(2):97-100. PubMed ID: 5704635 [No Abstract] [Full Text] [Related]
29. Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. Rengstorff RH; Doughty CB Am J Optom Physiol Opt; 1982 Feb; 59(2):162-77. PubMed ID: 7039329 [TBL] [Abstract][Full Text] [Related]
30. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Moncrieff J Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655 [TBL] [Abstract][Full Text] [Related]
31. Oculogyric crisis with exacerbation of psychosis: Possible mechanism and clinical implications. Thomas N; Sankar SS; Braganza D; Jayakrishnan S Neurosci Lett; 2009 Feb; 451(1):50-1. PubMed ID: 19121367 [TBL] [Abstract][Full Text] [Related]
32. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]. Khaldi S; Kornreich C; Choubani Z; Gourevitch R Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460 [TBL] [Abstract][Full Text] [Related]
33. [Atopic dermatitis with persistent reaction to light and primary cutaneous amyloidosis]. Amblard P; Reymond JL; Beani JC Ann Dermatol Venereol; 1982; 109(3):265-8. PubMed ID: 6126149 [No Abstract] [Full Text] [Related]
34. Neuroleptic malignant syndrome and acute myocardial infarction: case report and review. Freedman MD Md Med J; 1997 Aug; 46(7):357-9. PubMed ID: 9260471 [TBL] [Abstract][Full Text] [Related]
35. Prolonged pharmacotherapy and the eye. A symposium. The antimalarials and the tranquilizers. Rubin M Dis Nerv Syst; 1968 Mar; 29(3):Suppl:67-76. PubMed ID: 4233735 [No Abstract] [Full Text] [Related]
36. Sex differences in long-term adverse effects of phenothiazines. Lehmann HE; Ban TA Adv Biochem Psychopharmacol; 1974; 9(0):249-54. PubMed ID: 4151763 [No Abstract] [Full Text] [Related]
37. [A case of malignant syndrome triggered by the use of haloperidol and chrorpromazine]. Konishi K; Fujimoto K; Kubota M; Ogawa H Masui; 1997 Apr; 46(4):547-8. PubMed ID: 9128030 [TBL] [Abstract][Full Text] [Related]
38. Management of a case of neuroleptic malignant syndrome with bromocriptine. Zubenko G; Pope HG Am J Psychiatry; 1983 Dec; 140(12):1619-20. PubMed ID: 6650696 [TBL] [Abstract][Full Text] [Related]
39. [Ocular complications in chronic psychiatric patients caused by prolonged use of antipsychotic drugs (author's transl)]. Yang Y Zhonghua Yan Ke Za Zhi; 1979; 15(3):198-200. PubMed ID: 45367 [No Abstract] [Full Text] [Related]
40. An overview of side effects caused by typical antipsychotics. Arana GW J Clin Psychiatry; 2000; 61 Suppl 8():5-11; discussion 12-3. PubMed ID: 10811237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]